Accelerate Biomarker-Based Drug Discovery with Next-Gen Preclinical Models & Human Biospecimens

At PlexoBio, we optimize the selection of preclinical models and human biospecimens for biomarker-based drug discovery. While our digital platform is in development, we offer expert, personalized support to help you access ethically sourced biospecimens and advanced models like organ-on-a-chip, 3D cell cultures, and in silico simulations. Our team ensures secure, transparent data management, streamlining your research. Accelerate your drug discovery with our expert solutions.

Discover Services

How It Works

At PlexoBio, we offer personalized, hands-on support to help you access the highest quality preclinical models and human biospecimens. Here’s how we help you accelerate your research:

  1. Consultation & Requirements Assessment
    We work closely with you to understand your specific research needs and help identify the most relevant preclinical models and human biospecimens for your project.
  2. Custom Model & Biospecimen Selection
    Our expert team manually selects and sources the ideal preclinical models, including organ-on-a-chip, 3D cell cultures, and ethically acquired human biospecimens, ensuring they meet your research criteria.
  3. Secure Data Management
    We ensure secure handling of all data through industry-standard practices, maintaining transparency and integrity in every step of the process.
  4. Delivery & Ongoing Support
    Once the models and biospecimens are selected, we facilitate delivery to your research site, providing continuous support throughout your project to ensure success.

As we continue to develop our AI and Blockchain-powered digital platform, we remain committed to offering a streamlined and efficient experience, powered by expert knowledge and personalized service.

Why Choose PlexoBio?

With deep expertise in the fields, we offer tailored solutions that directly support advancements in cancer, fibrosis, and cardiovascular disease research.

We are dedicated to providing the highest quality, ethically sourced, data-driven preclinical models and biospecimens, ensuring that your research is accurate and aligned with global standards.

🤝 Access Next-Gen Preclinical Models

Leverage state-of-the-art preclinical models to enhance drug development efficiency and accuracy. Whether you need computational models, microphysiological systems, or complex cell cultures, PlexoBio connects you with leading-edge providers.

🤝 Access Human Biospecimens for Research Use

Leverage state-of-the-art biorepositories to enable translational research and precision medicine for patients. Whether you need to support studies in genomics, pathology, drug development, and personalized medicine, PlexoBio connects you with leading-edge providers.

🤝 Seamless Collaboration

Find, compare, and engage with top-tier preclinical model and human biospecimen providers effortlessly. Our platform streamlines the process, ensuring you get the right models tailored to your research needs.

🤝Accelerate Drug Discovery

Reduce timelines and optimize resources by accessing innovative models that improve predictability and reduce reliance on traditional animal testing.

Advancing Health Through Innovation

At PlexoBio, we accelerate the future of drug discovery by making cutting-edge preclinical models and human biospecimens more accessible, equitable, and impactful. Our services go beyond helping clients select the best models—we empower them to innovate, optimize, and drive breakthroughs that transform lives.

We’re not just a marketplace; we’re a catalyst for change. Join us in pioneering a smarter, healthier world.

Learn More

Blog

Explore expert-driven articles, industry insights, and resources that inspire innovation in the life sciences sector.

Advancing Drug Discovery with Expert Guidance

Learn how PlexoBio is empowering researchers and biopharma innovators by providing tailored preclinical solutions that accelerate the drug discovery process.

Thanks to the PlexoBio team’s support, we gained access to high-quality human cancer biospecimens—transforming our preclinical research and boosting accuracy, efficiency, and clinical relevance.

Client 1

Oncology Research Group Leader

With the help of the PlexoBio team, we identified and implemented the perfect preclinical cancer model, boosting the accuracy of our drug development process.

Client 2

Senior Oncology Research Scientist

With PlexoBio, we gained access to top-tier fibrosis preclinical models, speeding up our drug screening timeline.

Client 3

Epigenomics Researcher

Thanks to PlexoBio’s expertise, we gained access to high-quality human lung fibrosis biospecimens, transforming our preclinical research and enhancing clinical relevance.

Client 4

Pre-Clinical Researcher